From £41,935 with benefits, subject to skills and experience: The Francis Crick Institute: The Developmental Signalling Laboratory headed by Caroline Hill focuses on cell signalling in early vertebrate development and disease London (Central), London (Greater)

From £41,935 with benefits, subject to skills and experience: The Francis Crick Institute: The Developmental Signalling Laboratory headed by Caroline Hill focuses on cell signalling in early vertebrate development and disease London (Central), London (Greater)

Notice NOT-DE-24-002 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AT-24-006 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) announcement is to support the development and maintenance of a Resource Center for Cannabis and Cannabinoid Research through a cooperative agreement funding mechanism (U24). Such a Center will address challenges and barriers to conducting research on cannabis and its constituents as well as to enable researchers to successfully generate more rigorous scientific evidence across a variety of research domains in both basic and clinical research. The Center is expected to be a focal point for researchers entering the cannabis research space and to support the development and establishment of research tools and studies that will improve upon and eventually change the landscape of cannabis research. Overall, the Center will facilitate research advances through synergistic interactions among experts in relevant commercial, basic science, clinical, and regulatory areas both within the Center itself and in collaboration with the extramural community.

Notice NOT-OD-24-001 from the NIH Guide for Grants and Contracts

Exact Sciences: Position Overview The Senior Bioinformatics QA Engineer will play a pivotal role in ensuring the quality and reliability of our bioinformatics soft... San Diego, California

Lead, coordinate, and manage the implementation of human research design, setup, data collection, and analysis. 13 paid holidays (staff holiday calendar).
From West Virginia University - Wed, 25 Oct 2023 22:12:08 GMT - View all Morgantown, WV jobs

Funding Opportunity PAS-24-058 from the NIH Guide for Grants and Contracts. The purpose of this NIDCD initiative is to encourage research in the development, characterization, and reproducibility/reliability of human auditory and vestibular organoids.Applications investigating animal organoids are allowable but only if accompanying comparative or other integrated companion studies with human organoids. Singular animal organoid studies alone are not responsive to this funding opportunity. This funding opportunity encourages innovative, reproducible, and novel methodologies and technologies that will drive the reproducibility and holistic longevity of hearing/balance sensory organoids as model systems. The development of novel tools to deliver genes, proteins, molecules, and synthetics that might lead to the successful expansion and longer-term survivability of organoid populations in a stable, reliable, and reproducible manner is highly encouraged. Subsequent characterization of the organoid platforms must be shown to mimic and recapitulate the native correlative biological function. Applications that provide approaches that remove current barriers and lessen challenges to improve current reproducibility and stability are highly encouraged. Applications that have breakthrough approaches and technologies using human auditory/vestibular organoids are highly encouraged.

Funding Opportunity PAS-24-057 from the NIH Guide for Grants and Contracts. The purpose of this NIDCD initiative is to encourage research in the development, characterization, and reproducibility/reliability of human auditory and vestibular organoids. Proposals investigating animal organoids are allowable but only if accompanying comparative or other integrated companion studies with human organoids. Singular animal organoid studies alone are not responsive to this funding opportunity. This funding opportunity encourages innovative, reproducible, and novel methodologies and technologies that will drive the reproducibility and holistic longevity of hearing/balance sensory organoids as model systems. The development of novel tools to deliver genes, proteins, molecules, and synthetics that might lead to the successful expansion and longer-term survivability of organoid populations in a stable, reliable, and reproducible manner is highly encouraged. Subsequent characterization of the organoid platforms must be shown to mimic and recapitulate the native correlative biological function. Applications that provide approaches that remove current barriers and lessen challenges to improve current reproducibility and stability are highly encouraged. Applications that have breakthrough approaches and technologies using human auditory/vestibular organoids are highly encouraged.

Funding Opportunity RFA-AI-23-060 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support the late-stage engineering and preclinical development of innovative biological products that safely and specifically kill HIV-infected cells. Products of interest include but are not limited to broadly neutralizing antibodies (bNAbs), their derivatives, and other soluble, antibody-like molecules.

Funding Opportunity RFA-AI-23-061 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to accelerate the development of safe and effective long-acting drug delivery systems for improved, simplified treatment of HIV-1 in children. This NOFO invites applicants engaged in the development of existing long-acting platforms at early stages of development stages to perform specific preclinical activities that enable product optimization and accelerated translation to HIV-infected children. Collaborative research partnerships with industry are required.

EUR 40,000 (the salary will reflect the successful candidate’s qualifications and can be higher): CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences: The Biomedical Sequencing Facility at the CeMM Research Center for Molecular Medicine of the Austrian... Vienna, Austria

Notice NOT-MH-24-290 from the NIH Guide for Grants and Contracts

Notice NOT-DA-23-044 from the NIH Guide for Grants and Contracts

Notice NOT-AI-23-073 from the NIH Guide for Grants and Contracts

$270,000 to $330,000: Vaccitech: Leading the Statistics and Data Management teams. 20874, Germantown (US)

£130,000 to £170,000: Vaccitech: Leading the Statistics and Data Management teams. OX11 0DF, Didcot

Notice NOT-DC-24-007 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-25-052 from the NIH Guide for Grants and Contracts. There are gaps that prevent the utilization of decentralized clinical trials (DCT) in substance use area. The existing sensors for physiological measurement are rarely used and may need further validation. There are no wearable or home-use detection devices on the market capable to measure substances of interest (e.g., methadone, buprenorphine, their metabolites, as well as the spectrum of illicit drugs). The devices in development are not intended for diagnostics or treatment. Most of the devices are intended for laboratory use. Most of the devices do not have standard software interface through which the devices can transmit the data to the study center.

Funding Opportunity RFA-DA-25-051 from the NIH Guide for Grants and Contracts. There are gaps that prevent the utilization of decentralized clinical trials (DCT) in substance use area. The existing sensors for physiological measurement are rarely used and may need further validation. There are no wearable or home-use detection devices on the market capable to measure substances of interest (e.g., methadone, buprenorphine, their metabolites, as well as the spectrum of illicit drugs). The devices in development are not intended for diagnostics or treatment. Most of the devices are intended for laboratory use. Most of the devices do not have standard software interface through which the devices can transmit the data to the study center.